SG11201400717QA - Pyrazoloquinoline derivative - Google Patents
Pyrazoloquinoline derivativeInfo
- Publication number
- SG11201400717QA SG11201400717QA SG11201400717QA SG11201400717QA SG11201400717QA SG 11201400717Q A SG11201400717Q A SG 11201400717QA SG 11201400717Q A SG11201400717Q A SG 11201400717QA SG 11201400717Q A SG11201400717Q A SG 11201400717QA SG 11201400717Q A SG11201400717Q A SG 11201400717QA
- Authority
- SG
- Singapore
- Prior art keywords
- pyrazoloquinoline derivative
- pyrazoloquinoline
- derivative
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161544860P | 2011-10-07 | 2011-10-07 | |
US201161550623P | 2011-10-24 | 2011-10-24 | |
US201161558110P | 2011-11-10 | 2011-11-10 | |
US201161580903P | 2011-12-28 | 2011-12-28 | |
PCT/JP2012/075748 WO2013051639A1 (en) | 2011-10-07 | 2012-10-04 | Pyrazoloquinoline derivative |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201400717QA true SG11201400717QA (en) | 2014-06-27 |
Family
ID=48043792
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201400717QA SG11201400717QA (en) | 2011-10-07 | 2012-10-04 | Pyrazoloquinoline derivative |
Country Status (33)
Country | Link |
---|---|
US (2) | US8563565B2 (en) |
EP (1) | EP2769980B1 (en) |
JP (1) | JP5546693B2 (en) |
KR (1) | KR101943680B1 (en) |
CN (1) | CN103930423B (en) |
AR (1) | AR088235A1 (en) |
AU (1) | AU2012319549B2 (en) |
BR (1) | BR112014007912B1 (en) |
CA (1) | CA2861795C (en) |
CL (1) | CL2014000821A1 (en) |
CO (1) | CO6910200A2 (en) |
CY (1) | CY1117427T1 (en) |
DK (1) | DK2769980T3 (en) |
ES (1) | ES2568015T3 (en) |
HK (1) | HK1199018A1 (en) |
HR (1) | HRP20160273T1 (en) |
HU (1) | HUE028555T2 (en) |
IL (1) | IL231650A (en) |
IN (1) | IN2014CN02463A (en) |
JO (1) | JO3116B1 (en) |
ME (1) | ME02394B (en) |
MX (1) | MX358149B (en) |
MY (1) | MY167698A (en) |
PE (1) | PE20141557A1 (en) |
PL (1) | PL2769980T3 (en) |
RS (1) | RS54702B1 (en) |
RU (1) | RU2605096C2 (en) |
SG (1) | SG11201400717QA (en) |
SI (1) | SI2769980T1 (en) |
SM (1) | SMT201600108B (en) |
TW (1) | TWI562993B (en) |
WO (1) | WO2013051639A1 (en) |
ZA (1) | ZA201402439B (en) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR112015007731B1 (en) | 2011-10-10 | 2022-05-31 | H. Lundbeck A/S | Compound, pharmaceutical composition comprising it and use thereof |
WO2014163147A1 (en) * | 2013-04-05 | 2014-10-09 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | Salt of pyrazoloquinoline derivative, and crystal thereof |
ES2654094T3 (en) * | 2013-04-05 | 2018-02-12 | Eisai R&D Management Co., Ltd. | Pyridinylpyrazoloquinoline compounds |
GB201406486D0 (en) | 2014-04-10 | 2014-05-28 | Redx Pharma Ltd | Antibacterial compounds |
WO2016021192A1 (en) * | 2014-08-08 | 2016-02-11 | Eisai R&D Management Co., Ltd. | Process for production of (s)-(tetrahydrofuran-3-yl)hydrazine |
AU2016289856B2 (en) | 2015-07-07 | 2020-11-26 | H. Lundbeck A/S | PDE9 inhibitors with imidazo triazinone backbone and imidazo pyrazinone backbone for treatment of peripheral diseases |
WO2017046606A1 (en) * | 2015-09-18 | 2017-03-23 | Redx Pharma Plc | Antibacterial compounds |
CN107056690A (en) * | 2017-03-22 | 2017-08-18 | 上海康鹏科技有限公司 | A kind of preparation method of the formaldehyde of 6 bromopyridine 3 |
WO2018221546A1 (en) * | 2017-06-01 | 2018-12-06 | Eisai R&D Management Co., Ltd. | Pharmaceutical composition comprising pde9 inhibitor |
WO2018221545A1 (en) * | 2017-06-01 | 2018-12-06 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | Dementia therapeutic agent combining pyrazoloquinoline derivative and donepezil |
KR102627790B1 (en) * | 2017-06-01 | 2024-01-23 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | Dementia treatment using a combination of pyrazoloquinoline derivatives and memantine |
US11311530B2 (en) | 2017-06-01 | 2022-04-26 | Eisai R&D Management Co., Ltd. | Lewy body disease therapeutic agent containing pyrazoloquinoline derivative |
CN111630042A (en) * | 2018-01-23 | 2020-09-04 | 巴斯夫欧洲公司 | Halogenation of pyridine derivatives |
KR20210053948A (en) * | 2018-08-31 | 2021-05-12 | 이마라 인크. | PDE9 inhibitors for treatment of sickle cell disease |
EP3894403A1 (en) * | 2018-12-13 | 2021-10-20 | Intervet International B.V. | Process for preparing 1-[(3r,4s)-4-cyanotetrahydropyran-3-yl]-3-[(2-fluoro-6-methoxy-4-pyridyl)amino]p yrazole-4-carboxamide |
US11883461B2 (en) | 2019-05-09 | 2024-01-30 | The Feinstein Institutes For Medical Research | HMGB1 antagonist treatment of severe sepsis |
WO2020227592A1 (en) | 2019-05-09 | 2020-11-12 | The Feinstein Institutes For Medical Research | Thiosemicarbazates and uses thereof |
WO2020227603A1 (en) | 2019-05-09 | 2020-11-12 | The Feinstein Institutes For Medical Research | Hmgb1 antagonist |
US10919882B2 (en) | 2019-05-09 | 2021-02-16 | The Feinstein Institutes For Medical Research | Compounds for use in synthesis of peptidomimetics |
US11530218B2 (en) | 2020-01-20 | 2022-12-20 | Incyte Corporation | Spiro compounds as inhibitors of KRAS |
US11739102B2 (en) | 2020-05-13 | 2023-08-29 | Incyte Corporation | Fused pyrimidine compounds as KRAS inhibitors |
WO2022002838A1 (en) | 2020-06-30 | 2022-01-06 | Bayer Aktiengesellschaft | Substituted heteroaryloxypyridines, the salts thereof and their use as herbicidal agents |
US11767320B2 (en) | 2020-10-02 | 2023-09-26 | Incyte Corporation | Bicyclic dione compounds as inhibitors of KRAS |
US11939328B2 (en) | 2021-10-14 | 2024-03-26 | Incyte Corporation | Quinoline compounds as inhibitors of KRAS |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2426734C2 (en) * | 2003-10-03 | 2011-08-20 | Зм Инновейтив Пропертиз Компани | Pyrazolopyridines and analogues thereof |
US20060035920A1 (en) * | 2004-05-28 | 2006-02-16 | Millennium Pharmaceuticals, Inc. | Chk-1 inhibitors |
WO2007032466A1 (en) | 2005-09-15 | 2007-03-22 | Aska Pharmaceutical Co., Ltd. | Heterocyclic compound, and production process and use thereof |
JP2009184924A (en) | 2006-05-31 | 2009-08-20 | Eisai R & D Management Co Ltd | Compound for biological reagent |
US8299080B2 (en) * | 2006-12-13 | 2012-10-30 | Aska Pharmaceutical Co., Ltd. | Substituted imidazo[1,5-A] quinoxalines as a PDE9 inhibitor |
CA2687035C (en) | 2007-05-11 | 2011-09-20 | Pfizer Inc. | Amino-heterocyclic compounds |
UA105362C2 (en) | 2008-04-02 | 2014-05-12 | Бьорингер Ингельхайм Интернациональ Гмбх | 1-heterocyclyl-1, 5-dihydro-pyrazolo [3, 4-d] pyrimidin-4-one derivatives and their use as pde9a modulators |
JP5609861B2 (en) * | 2009-03-05 | 2014-10-22 | アステラス製薬株式会社 | Quinoxaline compounds |
ES2460019T3 (en) | 2009-03-31 | 2014-05-13 | Boehringer Ingelheim International Gmbh | Derivatives of 1-heterocyclyl-1,5-dihydro-pyrazolo [3,4-d] pyrimidin-4-one and its use as PDE9A modulators |
US8880976B2 (en) | 2009-09-25 | 2014-11-04 | Stmicroelectronics, Inc. | Method and apparatus for encoding LBA information into the parity of a LDPC system |
ES2583528T3 (en) * | 2010-09-07 | 2016-09-21 | Astellas Pharma Inc. | Pyrazoloquinoline compound |
JP6042060B2 (en) * | 2011-09-26 | 2016-12-14 | サノフイ | Pyrazoloquinolinone derivatives, their preparation and therapeutic use |
-
2012
- 2012-10-04 IN IN2463CHN2014 patent/IN2014CN02463A/en unknown
- 2012-10-04 KR KR1020147008769A patent/KR101943680B1/en active IP Right Grant
- 2012-10-04 JO JOP/2012/0302A patent/JO3116B1/en active
- 2012-10-04 RS RS20160232A patent/RS54702B1/en unknown
- 2012-10-04 BR BR112014007912-9A patent/BR112014007912B1/en active IP Right Grant
- 2012-10-04 DK DK12837953.4T patent/DK2769980T3/en active
- 2012-10-04 EP EP12837953.4A patent/EP2769980B1/en active Active
- 2012-10-04 JP JP2013537544A patent/JP5546693B2/en active Active
- 2012-10-04 US US13/644,745 patent/US8563565B2/en active Active
- 2012-10-04 SI SI201230501A patent/SI2769980T1/en unknown
- 2012-10-04 HU HUE12837953A patent/HUE028555T2/en unknown
- 2012-10-04 AR ARP120103702A patent/AR088235A1/en active IP Right Grant
- 2012-10-04 CA CA2861795A patent/CA2861795C/en active Active
- 2012-10-04 RU RU2014112931/04A patent/RU2605096C2/en active
- 2012-10-04 SG SG11201400717QA patent/SG11201400717QA/en unknown
- 2012-10-04 CN CN201280046653.2A patent/CN103930423B/en active Active
- 2012-10-04 MX MX2014003800A patent/MX358149B/en active IP Right Grant
- 2012-10-04 ME MEP-2016-65A patent/ME02394B/en unknown
- 2012-10-04 PE PE2014000408A patent/PE20141557A1/en active IP Right Grant
- 2012-10-04 AU AU2012319549A patent/AU2012319549B2/en active Active
- 2012-10-04 PL PL12837953T patent/PL2769980T3/en unknown
- 2012-10-04 WO PCT/JP2012/075748 patent/WO2013051639A1/en active Application Filing
- 2012-10-04 MY MYPI2014700702A patent/MY167698A/en unknown
- 2012-10-04 TW TW101136747A patent/TWI562993B/en active
- 2012-10-04 ES ES12837953.4T patent/ES2568015T3/en active Active
-
2013
- 2013-06-11 US US13/914,898 patent/US20130296352A1/en not_active Abandoned
-
2014
- 2014-03-19 CO CO14059034A patent/CO6910200A2/en active IP Right Grant
- 2014-03-20 IL IL231650A patent/IL231650A/en active IP Right Grant
- 2014-04-02 ZA ZA2014/02439A patent/ZA201402439B/en unknown
- 2014-04-03 CL CL2014000821A patent/CL2014000821A1/en unknown
- 2014-12-08 HK HK14112316.6A patent/HK1199018A1/en unknown
-
2016
- 2016-03-17 HR HRP20160273TT patent/HRP20160273T1/en unknown
- 2016-04-12 CY CY20161100302T patent/CY1117427T1/en unknown
- 2016-04-14 SM SM201600108T patent/SMT201600108B/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20180646T1 (en) | Dispiropyrrolidine derivative | |
ZA201402439B (en) | Pyrazoloquinoline derivative | |
DK3798230T3 (en) | Terapeutiske antistoffer | |
IL247637B (en) | Heteroarylpiperidine derivatives | |
IL231950B (en) | Aryl-quinoline derivatives | |
HK1200314A1 (en) | R()-n-methyl-propargyl-aminoindan r()-n--- | |
AP2014007621A0 (en) | 2-Thiopyrimidinones | |
HK1200315A1 (en) | R()-n-formyl-propargyl-aminoindan r()-n--- | |
EP2721029A4 (en) | Imidazopyridin-2-one derivatives | |
EP2687531A4 (en) | Tetrahydrocarboline derivative | |
EP2740730A4 (en) | Dibenzooxepin derivative | |
EP2679138A4 (en) | Endsoscope | |
EP2684382A4 (en) | Earpuff | |
SI2766342T1 (en) | Phenyl-guanidine derivatives | |
EP2694655A4 (en) | pAVEC | |
ZA201308049B (en) | 3-ureidoisoquinolin-8-yl derivatives | |
GB2512771B (en) | Ablutionary fitting | |
AU4540P (en) | BUNNAN Baloskion tetraphyllum | |
AU5171P (en) | Sunparamiho Mandevilla xamabilis | |
AU5026P (en) | Goldstrike Agapanthus inapertus | |
ZA201209319B (en) | Cyclopropyl-indole derivatives | |
AP00723S1 (en) | Autorickshaw | |
AU2011303V (en) | Silverado Dianella tasmanica | |
AU339857S (en) | Orchidometer | |
AU338110S (en) | Barstool |